18+ Years
This is a phase III, multinational, multicenter, randomized, double-blind, 2-arm parallel group study. Comparing efficacy, safety and tolerability of the fixed dose triple combination of Beclomethasone Dipropionate/Fluticasone Furoate/Glycopyrronium Bromide 100/6/12.5µg with the fixed dose dual combination of Beclomethasone Dipropionate/Fluticasone Furoate 100/6µg. The study will last approximately 55 weeks for each subject.